Balamurali K. Ambati

Executive Officer, Director at Inflammasome Therapeutics.

Raised on Inflammasome Therapeutics filings

$13.2M

of $13.2M offered across 1 Form D filing

Company

Biotech · Newton, MA

Inflammasome inhibitor implants for geographic atrophy

Inflammasome inhibitor implants for geographic atrophy

Inflammasome Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
May 4, 2026	Equity	$13.2M/ $13.2M	Form D

Also named on Inflammasome Therapeutics filings